2025 annual financial data

Aquestive Therapeutics 2025 Operating margin

Direct answer

Operating margin was -156.36%.

Operating income was -69.65M USD and net income was -83.78M USD.
Operating cash flow was -52.43M USD.

Get free Aquestive Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
44.55M USD
Operating income
-69.65M USD
Net income
-83.78M USD
Operating cash flow
-52.43M USD